Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors.

Hou, Mingyan ; Harden, T Kendall ; Kuhn, Cynthia M ; Baldetorp, Bo LU ; Lazarowski, Eduardo ; Pendergast, William ; Möller, Sebastian ; Edvinsson, Lars LU and Erlinge, David LU orcid (2002) In American Journal of Physiology: Heart and Circulatory Physiology 282(2). p.784-792
Abstract
Mitogenic effects of the extracellular nucleotides ATP and UTP are mediated by P2Y(1), P2Y(2), and P2Y(4) receptors. However, it has not been possible to examine the highly expressed UDP-sensitive P2Y(6) receptor because of the lack of stable, selective agonists. In rat aorta smooth muscle cells (vascular smooth muscle cells; VSMC), UDP and UTP stimulated (3)H-labeled thymidine incorporation with similar pEC(50) values (5.96 and 5.69). Addition of hexokinase did not reduce the mitogenic effect of UDP. In cells transfected with P2Y receptors the stable pyrimidine agonist uridine 5'-O-(2-thiodiphosphate) (UDPbetaS) was specific for P2Y(6) with no effect on P2Y(1), P2Y(2), or P2Y(4) receptors. UDPbetaS stimulated [(3)H]thymidine and... (More)
Mitogenic effects of the extracellular nucleotides ATP and UTP are mediated by P2Y(1), P2Y(2), and P2Y(4) receptors. However, it has not been possible to examine the highly expressed UDP-sensitive P2Y(6) receptor because of the lack of stable, selective agonists. In rat aorta smooth muscle cells (vascular smooth muscle cells; VSMC), UDP and UTP stimulated (3)H-labeled thymidine incorporation with similar pEC(50) values (5.96 and 5.69). Addition of hexokinase did not reduce the mitogenic effect of UDP. In cells transfected with P2Y receptors the stable pyrimidine agonist uridine 5'-O-(2-thiodiphosphate) (UDPbetaS) was specific for P2Y(6) with no effect on P2Y(1), P2Y(2), or P2Y(4) receptors. UDPbetaS stimulated [(3)H]thymidine and [(3)H]leucine incorporation and increased cell number in VSMC. Flow cytometry demonstrated that UDP stimulated cell cycle progression to both the S and G(2) phases. The intracellular signal pathways were dependent on phospholipase C, possibly protein kinase C-delta, and a tyrosine kinase pathway but independent of G(i) proteins, eicosanoids, and protein kinase A. The half-life of P2Y(6) receptor mRNA was <1 h by competitive RT-PCR. The mitogen-activated protein kinase kinase inhibitor PD-098059 significantly suppressed, whereas ATP and interleukin-1beta upregulated, expression of P2Y(6) receptor mRNA. The results demonstrate that UDP stimulates mitogenesis through activation of P2Y(6) receptors and that the receptor is regulated by factors important in the development of vascular disease. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Flavones : pharmacology, Growth Substances : pharmacology, Inositol Phosphates : metabolism, Mitogen-Activated Protein Kinase Kinases : antagonists & inhibitors : metabolism, Muscle Smooth Vascular : cytology : drug effects : metabolism, Phospholipase C : metabolism, Protein Kinases : metabolism, Rats, Rats Sprague-Dawley, Receptors Purinergic P2 : agonists : metabolism, Support Non-U.S. Gov't, Thionucleotides : pharmacology, Thymidine : pharmacokinetics, Tritium : diagnostic use, Uridine Triphosphate : analogs & derivatives : pharmacology, Uridine Diphosphate : analogs & derivatives : pharmacology, Epithelial Cells : cytology : metabolism, Enzyme Inhibitors : pharmacology, DNA : biosynthesis, Animal, Aorta : cytology, Cell Survival : drug effects, Cells Cultured, Cyclic AMP : pharmacology
in
American Journal of Physiology: Heart and Circulatory Physiology
volume
282
issue
2
pages
784 - 792
publisher
American Physiological Society
external identifiers
  • wos:000173416900047
  • pmid:11788430
  • scopus:0036084809
ISSN
1522-1539
DOI
10.1152/ajpheart.00997.2000
language
English
LU publication?
yes
id
cbe2c97c-7ce7-414a-b2f1-fab37b26cb73 (old id 106708)
alternative location
http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11788430&dopt=Abstract
date added to LUP
2016-04-01 12:11:02
date last changed
2024-01-08 11:22:21
@article{cbe2c97c-7ce7-414a-b2f1-fab37b26cb73,
  abstract     = {{Mitogenic effects of the extracellular nucleotides ATP and UTP are mediated by P2Y(1), P2Y(2), and P2Y(4) receptors. However, it has not been possible to examine the highly expressed UDP-sensitive P2Y(6) receptor because of the lack of stable, selective agonists. In rat aorta smooth muscle cells (vascular smooth muscle cells; VSMC), UDP and UTP stimulated (3)H-labeled thymidine incorporation with similar pEC(50) values (5.96 and 5.69). Addition of hexokinase did not reduce the mitogenic effect of UDP. In cells transfected with P2Y receptors the stable pyrimidine agonist uridine 5'-O-(2-thiodiphosphate) (UDPbetaS) was specific for P2Y(6) with no effect on P2Y(1), P2Y(2), or P2Y(4) receptors. UDPbetaS stimulated [(3)H]thymidine and [(3)H]leucine incorporation and increased cell number in VSMC. Flow cytometry demonstrated that UDP stimulated cell cycle progression to both the S and G(2) phases. The intracellular signal pathways were dependent on phospholipase C, possibly protein kinase C-delta, and a tyrosine kinase pathway but independent of G(i) proteins, eicosanoids, and protein kinase A. The half-life of P2Y(6) receptor mRNA was &lt;1 h by competitive RT-PCR. The mitogen-activated protein kinase kinase inhibitor PD-098059 significantly suppressed, whereas ATP and interleukin-1beta upregulated, expression of P2Y(6) receptor mRNA. The results demonstrate that UDP stimulates mitogenesis through activation of P2Y(6) receptors and that the receptor is regulated by factors important in the development of vascular disease.}},
  author       = {{Hou, Mingyan and Harden, T Kendall and Kuhn, Cynthia M and Baldetorp, Bo and Lazarowski, Eduardo and Pendergast, William and Möller, Sebastian and Edvinsson, Lars and Erlinge, David}},
  issn         = {{1522-1539}},
  keywords     = {{Flavones : pharmacology; Growth Substances : pharmacology; Inositol Phosphates : metabolism; Mitogen-Activated Protein Kinase Kinases : antagonists & inhibitors : metabolism; Muscle Smooth Vascular : cytology : drug effects : metabolism; Phospholipase C : metabolism; Protein Kinases : metabolism; Rats; Rats Sprague-Dawley; Receptors Purinergic P2 : agonists : metabolism; Support Non-U.S. Gov't; Thionucleotides : pharmacology; Thymidine : pharmacokinetics; Tritium : diagnostic use; Uridine Triphosphate : analogs & derivatives : pharmacology; Uridine Diphosphate : analogs & derivatives : pharmacology; Epithelial Cells : cytology : metabolism; Enzyme Inhibitors : pharmacology; DNA : biosynthesis; Animal; Aorta : cytology; Cell Survival : drug effects; Cells Cultured; Cyclic AMP : pharmacology}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{784--792}},
  publisher    = {{American Physiological Society}},
  series       = {{American Journal of Physiology: Heart and Circulatory Physiology}},
  title        = {{UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors.}},
  url          = {{http://dx.doi.org/10.1152/ajpheart.00997.2000}},
  doi          = {{10.1152/ajpheart.00997.2000}},
  volume       = {{282}},
  year         = {{2002}},
}